Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization

Eijken, Marco, Swagemakers, Sigrid, Koedam, Marijke, Steenbergen, Cobie, Derkx, Pieter, Uitterlinden, André G., van der Spek, Peter J., Visser, Jenny A., de Jong, Frank H., Pols, Huibert A. P., van Leeuwen, Johannes P. T. M.·2007·The FASEB Journal

Abstract

Bone quality is an important determinant of osteoporosis, and proper osteoblast differentiation plays an important role in the control and maintenance of bone quality. We investigated the impact of activin signaling on human osteoblast differentiation, extracellular matrix formation, and mineralization. Ac‐tivins belong to the transforming growth factor‐β su‐perfamily and activin A treatment strongly inhibited mineralization in osteoblast cultures, whereas the ac‐tivin antagonist follistatin increased mineralization. Os‐teoblasts produced activin A and follistatin in a differentiation‐dependent manner, leading to autocrine regulation of extracellular matrix formation and mineralization. In addition, mineralization in a vascular smooth muscle cell‐based model for pathological calcification was inhibited. Comparative activin A and fol‐listatin gene expression profiling showed that activin signaling changes the expression of a specific range of extracellular matrix proteins prior to the onset of mineralization, leading to a matrix composition with reduced or no mineralizing capacity. These findings demonstrate the regulation of osteoblast differentiation and matrix mineralization by the activin A‐follista‐tin system, providing the possibility to control bone quality as well as pathological calcifications such as atherosclerosis by using activin A, follistatin, or analogs thereof.—Eijken M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., van der Spek P. J., Visser, J. A., de Jong F. H., Pols, H. A. P., van Leeuwen J. P. T. M. The activin A‐follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 21, 2949–2960 (2007)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.07-8080com

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. 10.1056/NEJMra053077 · DOI · Paper page
  2. Robey P. G., 2006, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
  3. 10.1161/hh2401.101070 · DOI · Paper page
  4. 10.1172/JCI117205 · DOI · Paper page
  5. 10.1161/01.ATV.0000133194.94939.42 · DOI · Paper page
  6. 10.1210/er.2002-0023 · DOI · Paper page
  7. 10.1002/jbmr.5650090611 · DOI · Paper page
  8. 10.1093/emboj/20.9.2254 · DOI · Paper page
  9. 10.1038/sj.emboj.7600067 · DOI · Paper page
  10. 10.1046/j.1432-1327.2000.01828.x · DOI · Paper page
  11. 10.1177/153537020623100507 · DOI · Paper page
  12. 10.1016/j.mce.2004.02.010 · DOI · Paper page
  13. 10.1172/JCI115827 · DOI
  14. 10.1074/jbc.270.11.6308 · DOI
  15. 10.1038/344868a0 · DOI · Paper page
  16. 10.2337/diabetes.53.8.2024 · DOI
  17. 10.1128/MCB.11.1.250 · DOI
  18. 10.1016/j.tem.2005.01.003 · DOI · Paper page
  19. 10.1126/science.2106159 · DOI · Paper page
  20. 10.1038/35006129 · DOI · Paper page
  21. 10.1210/en.138.7.2928 · DOI
  22. 10.1016/S0021-9258(19)49702-0 · DOI
  23. 10.1006/bbrc.1993.2006 · DOI
  24. 10.1210/endo.143.1.8580 · DOI
  25. 10.1016/S8756-3282(99)00152-0 · DOI
  26. 10.1007/s00223-001-2037-3 · DOI
  27. 10.1016/S0021-9258(18)42930-4 · DOI
  28. 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T · DOI
  29. 10.1210/me.2004-0212 · DOI
  30. 10.1016/j.mce.2005.11.034 · DOI
  31. 10.1093/emboj/17.11.3091 · DOI · Paper page
  32. 10.1074/jbc.M111023200 · DOI · Paper page
  33. 10.1093/bioinformatics/bth495 · DOI
  34. 10.1006/geno.2002.6748 · DOI · Paper page
  35. 10.1161/01.ATV.15.11.2003 · DOI · Paper page
  36. 10.1073/pnas.95.16.9337 · DOI · Paper page
  37. 10.1016/S0925-4773(97)00673-4 · DOI · Paper page
  38. 10.1016/S8756-3282(98)00139-2 · DOI
  39. 10.1007/s00467-004-1658-y · DOI
  40. 10.1051/rnd:2005031 · DOI
  41. 10.1016/S8756-3282(00)00307-0 · DOI
  42. 10.1016/S0303-7207(01)00496-8 · doi:10.1016/s0303-7207(01)00496-8
  43. 10.1038/374360a0 · DOI · Paper page
  44. 10.1210/mend.12.1.0053 · DOI · Paper page
  45. 10.1016/0006-291X(89)92795-2 · DOI · Paper page
  46. 10.1083/jcb.127.6.1767 · DOI
  47. 10.1016/S0014-4827(03)00213-1 · DOI · Paper page
  48. 10.1002/jcb.10272 · DOI
  49. Tenenbaum H. C., 1987, Chondroitin sulfate inhibits calcification of bone formed in vitro, Bone Miner., 2, 43
  50. 10.1097/01.mnh.0000168335.29381.23 · doi:10.1097/01.mnh.0000168335.29381.23
  51. 10.1161/01.CIR.101.8.850 · DOI · Paper page
  52. 10.1161/01.RES.85.10.931 · DOI
  53. 10.1016/0303-7207(94)03451-X · doi:10.1016/0303-7207(94)03451-x
  54. 10.1172/JCI24140 · doi:10.1172/jci24140 · Paper page

Cited by

See all 174

Metadata

Authors
Eijken, M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., van der Spek, P. J., Visser, J. A., de Jong, F. H., Pols, H. A. P., & van Leeuwen, J. P. T. M.
Venue
The FASEB Journal
Publisher
Wiley
Published
2007-04-20
Volume
21
Issue
11
Pages
2949-2960
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2169715549
Cited by
174
References
4
FWCI
2.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.